161 related articles for article (PubMed ID: 12893026)
1. Role of ascorbic acid in the modulation of inhibition of platelet aggregation by polymorphonuclear leukocytes.
Raghavan SA; Sharma P; Dikshit M
Thromb Res; 2003 May; 110(2-3):117-26. PubMed ID: 12893026
[TBL] [Abstract][Full Text] [Related]
2. Role of ascorbate in the regulation of nitric oxide generation by polymorphonuclear leukocytes.
Sharma P; Raghavan SA; Dikshit M
Biochem Biophys Res Commun; 2003 Sep; 309(1):12-7. PubMed ID: 12943656
[TBL] [Abstract][Full Text] [Related]
3. Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide.
Sharma P; Raghavan SA; Saini R; Dikshit M
J Leukoc Biol; 2004 Jun; 75(6):1070-8. PubMed ID: 15039465
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
5. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.
Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Balbo A; Trovati M
Thromb Res; 2002 Jan; 105(1):71-8. PubMed ID: 11864710
[TBL] [Abstract][Full Text] [Related]
6. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M
Thromb Res; 2001 May; 102(4):319-30. PubMed ID: 11369425
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
Dangel O; Mergia E; Karlisch K; Groneberg D; Koesling D; Friebe A
J Thromb Haemost; 2010 Jun; 8(6):1343-52. PubMed ID: 20149081
[TBL] [Abstract][Full Text] [Related]
8. Platelet hyperaggregability in high-fat fed rats: a role for intraplatelet reactive-oxygen species production.
Monteiro PF; Morganti RP; Delbin MA; Calixto MC; Lopes-Pires ME; Marcondes S; Zanesco A; Antunes E
Cardiovasc Diabetol; 2012 Jan; 11():5. PubMed ID: 22248260
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet activation by polymorphonuclear leukocytes.
Schattner MA; Geffner JR; Isturiz MA; Lazzari MA
Br J Pharmacol; 1990 Oct; 101(2):253-6. PubMed ID: 2257433
[TBL] [Abstract][Full Text] [Related]
10. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
Crane MS; Rossi AG; Megson IL
Br J Pharmacol; 2005 Mar; 144(6):849-59. PubMed ID: 15685209
[TBL] [Abstract][Full Text] [Related]
11. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect.
Trovati M; Massucco P; Mattiello L; Mularoni E; Cavalot F; Anfossi G
Diabetes; 1994 Aug; 43(8):1015-9. PubMed ID: 7518780
[TBL] [Abstract][Full Text] [Related]
12. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
Faint RW; Mackie IJ; Machin SJ
Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
[TBL] [Abstract][Full Text] [Related]
13. Ascorbate and dehydroascorbate modulate nitric oxide-induced vasodilations of rat coronary arteries.
Murphy ME
J Cardiovasc Pharmacol; 1999 Aug; 34(2):295-303. PubMed ID: 10445682
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
15. Cross-talking between lymphocytes and platelets and its regulation by nitric oxide and peroxynitrite in physiological condition and endotoxemia.
Almeida Cardelli NJ; Elisa Lopes-Pires M; Bonfitto PH; Ferreira HH; Antunes E; Marcondes S
Life Sci; 2017 Mar; 172():2-7. PubMed ID: 28017682
[TBL] [Abstract][Full Text] [Related]
16. Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregation.
Kempfert J; Behrends S
Platelets; 2003; 14(7-8):429-35. PubMed ID: 14713512
[TBL] [Abstract][Full Text] [Related]
17. Reduction of platelet surface GPIb expression induced by polymorphonuclear leukocytes.
Schattner M; Kempfer A; Geffner J; Bermejo E; Frontroth JP; Lazzari M
Thromb Res; 1995 Aug; 79(3):319-24. PubMed ID: 8533127
[TBL] [Abstract][Full Text] [Related]
18. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
Matsuoka I; Suzuki T
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
[TBL] [Abstract][Full Text] [Related]
20. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Nezu A; Shinoda H; Minami M
Br J Pharmacol; 1996 Jan; 117(2):299-304. PubMed ID: 8789382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
